CN117689404A - Drug supply and marketing evaluation management system - Google Patents

Drug supply and marketing evaluation management system Download PDF

Info

Publication number
CN117689404A
CN117689404A CN202311587244.XA CN202311587244A CN117689404A CN 117689404 A CN117689404 A CN 117689404A CN 202311587244 A CN202311587244 A CN 202311587244A CN 117689404 A CN117689404 A CN 117689404A
Authority
CN
China
Prior art keywords
sales
medicine
sales channel
feedback
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311587244.XA
Other languages
Chinese (zh)
Inventor
沈绍伟
夏华剑
朱赟
罗家友
杨晓栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aiyong Xingchen Pharmaceutical Technology Guangzhou Co ltd
Chongqing Aiyong Xingchen Enterprise Service Co ltd
Chongqing Aiyong Xingchen Standard Medical Service Co ltd
Original Assignee
Aiyong Xingchen Pharmaceutical Technology Guangzhou Co ltd
Chongqing Aiyong Xingchen Enterprise Service Co ltd
Chongqing Aiyong Xingchen Standard Medical Service Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aiyong Xingchen Pharmaceutical Technology Guangzhou Co ltd, Chongqing Aiyong Xingchen Enterprise Service Co ltd, Chongqing Aiyong Xingchen Standard Medical Service Co ltd filed Critical Aiyong Xingchen Pharmaceutical Technology Guangzhou Co ltd
Priority to CN202311587244.XA priority Critical patent/CN117689404A/en
Publication of CN117689404A publication Critical patent/CN117689404A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medical Treatment And Welfare Office Work (AREA)

Abstract

The invention discloses a drug supply and marketing evaluation management system, which relates to the technical field of drug supply and marketing evaluation, and comprises the following components: the system comprises a supply and sales information acquisition module, a medicine feedback information sampling module, a medicine supply and sales result evaluation module, a medicine management scheme analysis module and a database. The method has the advantages that the corresponding effective evaluation value, price evaluation value, verification evaluation value and language evaluation value of each sales channel are obtained through corresponding analysis, comprehensive analysis is carried out on the effective evaluation value, the price evaluation value, the verification evaluation value and the language evaluation value to obtain the feedback evaluation value of the corresponding medicine of each sales channel, the evaluation of the medicine by feedback personnel can be known in time, reliable data support is provided for subsequent analysis, and the medical requirements of the feedback personnel are met; and further, a management scheme of corresponding medicine supply and marketing is obtained through further analysis, so that comprehensiveness of understanding of market on medicine demand conditions is improved to a great extent, powerful support is provided for the management scheme of corresponding medicine supply and marketing, and risks of backlog of medicine inventory and outdated medicine growth are reduced to a certain extent.

Description

Drug supply and marketing evaluation management system
Technical Field
The invention relates to the technical field of drug supply and marketing evaluation, in particular to a drug supply and marketing evaluation management system.
Background
The main purpose of the evaluation of medicine supply and sales is to know the supply condition and sales condition of medicines in the market, and then to manage the supply and sales of medicines correspondingly, not only reduces stock backlog and the risk of overdue medicines, but also meets the demands of patients to a great extent, but the evaluation and management of the current medicine supply and sales have certain unilaterality, which results in imperfect management schemes, particularly in the following aspects:
the current drug supply and marketing evaluation management is generally managed through the sales condition of drugs, the feedback information of the drugs to the patients is ignored to be collected, the evaluation of the drugs by the patients cannot be known in time, corresponding measures cannot be taken in a targeted manner, and the medical requirements of the patients cannot be met accurately.
Due to the fact that feedback information of corresponding medicines of a patient is not analyzed, adverse reactions of the patient to the medicines and other problems to be improved are not found in time, corresponding management schemes cannot be adopted in time, and medication safety of the patient is reduced.
The current drug supply and marketing evaluation management often neglects to analyze the feedback condition of patients and the cost of drugs, so that the demand condition of the market for the drugs cannot be realized, the adjustment of the drug management scheme is not facilitated, and meanwhile, the risks of backlog of the drug inventory and the increase of overdue drugs are increased.
In summary, the comprehensive evaluation and analysis and reasonable management of drug delivery can help to provide better medical services for patients, and therefore, a drug delivery evaluation and management system is provided.
Disclosure of Invention
In view of the above-mentioned technical shortcomings, an object of the present invention is to provide a drug delivery evaluation management system, comprising:
and the sales information acquisition module is used for acquiring the sales unit price of each medicine corresponding to each sales channel in the set period, and acquiring the total sales information of the medicine corresponding to each sales channel in the set period based on the sales unit price, wherein the total sales information comprises the total sales amount and the total sales amount.
Preferably, the total sales information of the medicines corresponding to each sales channel in the set period is obtained by the following specific obtaining mode:
accumulating the sales prices of the medicines corresponding to the sales channels in the set period to obtain the total sales amount of the medicines corresponding to the sales channels in the set period;
counting the corresponding medicines of each sales channel in the set period to obtain the total sales quantity of the corresponding medicines of each sales channel in the set period;
the total sales amount and the total sales amount of the medicines corresponding to each sales channel in the fixed period form the total sales information of the medicines corresponding to each sales channel in the set period.
The medicine feedback information sampling inspection module is used for acquiring contact information of purchasing personnel corresponding to each medicine in each sales channel in a set period, randomly extracting contact information of a plurality of purchasing personnel in the contact information of each purchasing personnel corresponding to each sales channel in the set period, marking the purchasing personnel as feedback personnel to acquire the contact information of each feedback personnel corresponding to each sales channel in the set period, further carrying out a return visit on each feedback personnel corresponding to each sales channel according to a set return visit mode based on the contact information, and recording the return visit information to acquire feedback records of each feedback personnel corresponding to each sales channel in the set period, so as to analyze feedback evaluation values of the medicines corresponding to each sales channel in the set period and acquire feedback evaluation values of the medicines corresponding to each sales channel in the set period.
Preferably, the setting of feedback records of each sales channel corresponding to each feedback person in the period specifically includes: drug effect score, drug price score, purchase process experience score, and supplemental opinion speech segment.
Preferably, the feedback value of the medicine corresponding to each sales channel in the set period is analyzed, so as to obtain the feedback value of the medicine corresponding to each sales channel in the set period, and the specific analysis process is as follows:
extracting the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel from the feedback records of the sales channels corresponding to the feedback personnel in the set period, and analyzing the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel to obtain the keyword number N of the sales channels corresponding to the word class i j Influence factor Y corresponding to each word class of each sales channel i j I is represented as the number of each sales channel, i=1, 2,.. i
Further, the supplemental opinion speech segments of the feedback personnel corresponding to the sales channels are analyzed to obtain the keyword quantity of the word class corresponding to the sales channels and the influence factors of the word class corresponding to the sales channels, and the specific analysis steps are as follows:
performing text conversion on the supplemental opinion voice segments of the corresponding feedback personnel of each sales channel to obtain supplemental opinion text fields of the corresponding feedback personnel of each sales channel;
matching the supplemental opinion text field of each feedback person corresponding to each sales channel with a set reject word, if the supplemental opinion text field of a certain feedback person is successfully matched with the set reject word, marking the feedback person as a person to be rejected, thereby obtaining each person to be rejected corresponding to each sales channel, rejecting the person to be rejected from each feedback person corresponding to each sales channel, and marking the rest feedback person as a marked person;
extracting the supplemental opinion text fields of the sales channels corresponding to the marking personnel from the supplemental opinion text fields of the feedback personnel corresponding to the sales channels, and extracting keywords from the supplemental opinion text fields to obtain the keywords of the supplemental opinion of the marking personnel in the sales channels;
word class identification is carried out on keywords of supplementary opinions corresponding to all marking persons in all sales channels, word classes of keywords of supplementary opinions corresponding to all marking persons in all sales channels are obtained, the same word classes are integrated, keywords of words corresponding to all sales channels are obtained, the number of keywords of words corresponding to all sales channels is counted, and meanwhile influence factors corresponding to words corresponding to all sales channels are matched with influence factors corresponding to words stored in a database, so that influence factors corresponding to words corresponding to all sales channels are obtained.
Further, according to the formulaCalculating the corresponding language valuation YG of each sales channel i
Extracting the medicine effect score, the medicine price score and the purchasing process experience score of each sales channel corresponding to each feedback person from the feedback records of each sales channel corresponding to each feedback person in a set period, and screening the lowest medicine effect score FX corresponding to each sales channel i min Minimal drug effect score FX i max And calculating an average drug effect score FX corresponding to each sales channel i avg
Similarly, the lowest medicine price score FJ corresponding to each sales channel is obtained through analysis i min Maximum drug price score FJ i max And calculating an average drug price score FJ corresponding to each sales channel i avg
Similarly, the lowest purchase process experience score FY corresponding to each sales channel is obtained through analysis i min Highest purchase procedure experience score FY i max And calculating the highest purchase procedure body corresponding to each sales channelScore under test FY i avg
According to formula PX i =FX i min ×a1+FX i max ×a2+FX i avg Calculating effective value PX corresponding to each sales channel by using Xa 3 i A1, a2 and a3 are respectively expressed as the set weight factors corresponding to the lowest drug effect score, the lowest drug effect score and the average drug effect score;
according to formula PJ i =FJ i min ×a4+FJ i max ×a5+FJ i avg Calculating price estimation PJ corresponding to each sales channel by using Xa 6 i A4, a5 and a6 are respectively expressed as weight factors corresponding to the set lowest drug price score, highest drug price score and average drug price score;
according to formula PY i =FY i min ×a7+FY i max ×a8+FY i avg Calculating the corresponding verification value PY of each sales channel by using the x a9 i A7, a8 and a9 are respectively represented as the set weight factors corresponding to the lowest purchase process experience score, the highest purchase process experience score and the highest purchase process experience score;
according to the formula KG i =YG i ×b1+PX i ×b2+PJ i ×b3+PY i Calculating feedback value KG of corresponding medicines of each sales channel in a set period by Xb 4 i B1, b2, b3, b4 are respectively represented as weights corresponding to the set speech estimation value, the set evaluation value, the set price estimation value, and the set test estimation value.
And the medicine supply and sales result evaluation module is used for extracting the manufacturing cost corresponding to the medicine from the database, analyzing the profit estimation value of the medicine corresponding to each sales channel in the setting period based on the total sales information of the medicine corresponding to each sales channel in the setting period and the manufacturing cost corresponding to the medicine, and obtaining the profit estimation value of the medicine corresponding to each sales channel in the setting period, so that the result value of the medicine corresponding to each sales channel in the setting period is obtained by analyzing the result value of the medicine corresponding to each sales channel in the setting period based on the profit estimation value and the feedback estimation value corresponding to each sales channel in the setting period.
Preferably, the method analyzes the profit estimation value of the corresponding medicine of each sales channel in the set period based on the total sales information of the corresponding medicine of each sales channel in the set period and the manufacturing cost of the corresponding medicine, and obtains the profit estimation value of the corresponding medicine of each sales channel in the set period, wherein the specific analysis process is as follows:
extracting the total sales amount E of the corresponding medicines of each sales channel from the total sales information of the corresponding medicines of each sales channel in the set period i And total sales M i Extracting manufacturing cost C corresponding to the medicine from a database;
according to formula LG i =(E i ÷(M i X C))xu to calculate the profit value LG of the corresponding drug for each sales channel in the set period i U represents the set correction factor.
Preferably, the result value of the medicine corresponding to each sales channel in the set period is analyzed based on the benefit evaluation value and the feedback evaluation value corresponding to each sales channel in the set period, so as to obtain the result value of the medicine corresponding to each sales channel in the set period, wherein a specific analysis formula is as follows: CG (CG) i =KG i ×bk+LG i Xbg, wherein CG i The result value of the medicine corresponding to the ith sales channel in the set period is expressed, and bk and bg are respectively expressed as the set feedback value and the influence factor corresponding to the benefit value.
And the medicine management scheme analysis module is used for analyzing the management scheme of the corresponding supply and sales of the medicine based on the result value of the corresponding medicine of each sales channel in the set period to obtain the management scheme of the corresponding supply and sales of the medicine, sending the management scheme of the corresponding supply and sales of the medicine into the value display processor, and displaying the management scheme of the corresponding supply and sales of the medicine through the display processor.
Preferably, the management scheme of corresponding marketing of the medicine is analyzed based on the result value of corresponding medicine of each marketing channel in the set period, and the management scheme of corresponding marketing of the medicine is obtained, and the specific analysis mode is as follows:
and matching the result value of the medicine corresponding to each sales channel in the set period with the result value corresponding to each set management level to obtain the management level of the medicine corresponding to each sales channel, further matching the management level of the medicine corresponding to each sales channel with the management scheme corresponding to each set management level to obtain the management scheme of the medicine corresponding to each sales channel, and integrating the management schemes to obtain the management scheme of the medicine corresponding to supply and sales.
And the database is used for storing the influence factors corresponding to the word classes and storing the manufacturing cost corresponding to the medicine.
The invention has the beneficial effects that:
according to the invention, the number of keywords and influence factors corresponding to each word class in each sales channel are obtained by analyzing the supplementary opinion voice segments in the feedback records corresponding to each feedback person in each sales channel, and the corresponding language evaluation value of each sales channel is analyzed, so that the defect of feedback information analysis of corresponding medicines of patients in the prior art is overcome, adverse reactions of the patients to the medicines and timeliness of finding other problems to be improved are improved, and the corresponding management scheme is further facilitated to be adopted in time, and the medication safety of the patients is greatly reduced.
According to the invention, the corresponding effect evaluation value, price evaluation value and verification evaluation value of each sales channel are analyzed to obtain the corresponding effect evaluation value, price evaluation value and verification evaluation value of each sales channel, and comprehensive analysis is performed based on the corresponding language evaluation value of each sales channel to obtain the feedback evaluation value of the corresponding medicine of each sales channel, so that the evaluation of the medicine by feedback personnel can be known in time, meanwhile, reliable data support can be provided for subsequent analysis, and the medical requirements of the feedback personnel are met to a certain extent.
According to the invention, the profit estimation value of the corresponding medicine of each sales channel is obtained through analysis, the result value of the corresponding medicine of each sales channel in the set period is obtained based on the profit estimation value and the feedback estimation value analysis of each sales channel in the set period, and then the management scheme of the corresponding supply and sales of the medicine is obtained based on the analysis, so that the comprehensiveness of the market on the condition of medicine demand is improved to a great extent, a powerful support is provided for the management scheme of the corresponding supply and sales of the medicine, and the backlog of the medicine inventory and the risk of overdue medicine growth are reduced to a certain extent.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and other drawings can be obtained according to the drawings without inventive effort for a person skilled in the art.
Fig. 1 is a schematic diagram of system module connection.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Referring to fig. 1, the present invention is a drug delivery evaluation management system, comprising: the system comprises a supply and marketing information acquisition module, a drug feedback information sampling inspection module, a drug supply and marketing result evaluation module, a drug management scheme analysis module, a database and a display processor.
The sales information acquisition module is used for acquiring the sales unit price of each medicine corresponding to each sales channel in the set period, and acquiring the total sales information of the medicine corresponding to each sales channel in the set period based on the sales unit price, wherein the total sales information comprises total sales amount and total sales amount, and the specific acquisition mode is as follows:
and accumulating the sales prices of the medicines corresponding to the sales channels in the set period to obtain the total sales amount of the medicines corresponding to the sales channels in the set period.
And counting the corresponding medicines of each sales channel in the set period to obtain the total sales quantity of the corresponding medicines of each sales channel in the set period.
The total sales amount and the total sales amount of the medicines corresponding to each sales channel in the fixed period form the total sales information of the medicines corresponding to each sales channel in the set period.
In a particular embodiment, the sales channels include, but are not limited to: each sales platform on line, each pharmacy off line, each hospital off line, and each clinic off line.
The medicine feedback information sampling inspection module is used for acquiring contact information of buying staff corresponding to each medicine in each sales channel in a set period, randomly extracting contact information of a plurality of buying staff in the contact information of buying staff corresponding to each sales channel in the set period, marking the buying staff as feedback staff to acquire the contact information of feeding back staff corresponding to each sales channel in the set period, and further carrying out a return visit on the feeding back staff corresponding to each sales channel according to a set return visit mode based on the contact information, and recording to acquire feedback records of the feeding back staff corresponding to each sales channel in the set period, wherein the feedback records of the feeding back staff corresponding to each sales channel specifically comprise: drug effect score, drug price score, purchase process experience score, and supplemental opinion speech segment.
In a specific embodiment, the return visit is performed on each feedback person corresponding to each sales channel based on the contact manner of each feedback person corresponding to each sales channel in the set period according to a set return visit mode, where the specific return visit mode is as follows: telephone return visit is carried out on each feedback person in each sales channel through intelligent voice machine personnel, wherein the telephone return visit telephone technology of the intelligent voice machine personnel is specifically as follows: "please ask you how satisfied with the effect of the drug? Quite full, you give a few minutes? And automatically recording the score of the feedback personnel on the drug effect based on the feedback personnel answers. Similarly, the drug price score and the purchase process experience score are recorded, specifically: "please ask you how satisfied with the price of the drug? Quite full, you give a few minutes? Is you pleased with the purchase procedure experience for this drug? Quite full, you give a few minutes? And finally, obtaining the drug effect scores, the drug price scores and the purchase process experience scores of the feedback personnel corresponding to the sales channels in the set period.
Further, after the intelligent voice robot scores the drug effect, the drug price and the purchase process experience corresponding to each feedback person in each sales channel, inquiring the supplementary opinion of the drug corresponding to each feedback person in each sales channel, specifically: "do you ask what is you the opinion to supplement the drug? And starting the recording function to obtain the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel.
It should be noted that, according to relevant laws and regulations, in order to protect personal privacy of feedback personnel, the applicant may need to obtain and process personal information of feedback personnel in the present application. Here, the applicant is underway to make heavy commitments, will strictly adhere to relevant laws and regulations, be responsible for keeping personal information of the feedback person secret, and will not use the personal information of the feedback person for other purposes. Meanwhile, the applicant will also take necessary technical and organizational measures to ensure the safety and confidentiality of the personal information of the feedback personnel. The feedback personnel, while agreeing to provide personal information, also understand and agree with the above-mentioned authorizations and commitments.
Based on the feedback records of the corresponding feedback personnel of the sales channels in the setting period, the feedback values of the corresponding medicines of the sales channels in the setting period are analyzed to obtain the feedback values of the corresponding medicines of the sales channels in the setting period, and the specific analysis mode is as follows:
extracting the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel from the feedback records of the sales channels corresponding to the feedback personnel in the set period, and performing text conversion on the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel to obtain supplementary opinion text fields of the sales channels corresponding to the feedback personnel;
matching the supplemental opinion text field of each feedback person corresponding to each sales channel with a set reject word, if the supplemental opinion text field of a certain feedback person is successfully matched with the set reject word, marking the feedback person as a person to be rejected, thereby obtaining each person to be rejected corresponding to each sales channel, rejecting the person to be rejected from each feedback person corresponding to each sales channel, and marking the rest feedback person as a marked person;
in a specific embodiment, the set culling words include, but are not limited to: no opinion, no suggestion, no improvement. It should be noted that if a document segment other than the set reject word exists in the supplemental opinion text field of a feedback person, the feedback person cannot be recorded as the person to be rejected.
Extracting the supplemental opinion text fields of the sales channels corresponding to the marking personnel from the supplemental opinion text fields of the feedback personnel corresponding to the sales channels, and extracting keywords from the supplemental opinion text fields to obtain the keywords of the supplemental opinion of the marking personnel in the sales channels;
in a specific embodiment, keywords include, but are not limited to: reducing price, increasing yield, improving service and increasing purchase points.
Word class identification is carried out on keywords of supplementary opinions corresponding to all marker persons in all sales channels, word classes of keywords of supplementary opinions corresponding to all marker persons in all sales channels are obtained, the same word classes are integrated, keywords of word classes corresponding to all sales channels are obtained, and the number N of keywords of word classes corresponding to all sales channels is counted i j I is represented as the number of each sales channel, i=1, 2,.. i j
The number of keywords corresponding to each word class in each sales channel is normalized and the numerical value is obtained, and other subsequent labels in the invention are normalized and the numerical value is obtained.
According to the formulaCalculating the corresponding language valuation YG of each sales channel i
Extracting the corresponding sales channels from the feedback records of the feedback personnel corresponding to the sales channels in the set periodThe drug effect score, the drug price score and the purchasing process experience score of each feedback person are selected, and the lowest drug effect score FX corresponding to each sales channel is selected i min Minimal drug effect score FX i max And calculating an average drug effect score FX corresponding to each sales channel i avg
Similarly, the lowest medicine price score FJ corresponding to each sales channel is obtained through analysis i min Maximum drug price score FJ i max And calculating an average drug price score FJ corresponding to each sales channel i avg
Similarly, the lowest purchase process experience score FY corresponding to each sales channel is obtained through analysis i min Highest purchase procedure experience score FY i max And calculating the highest purchase process experience score FY corresponding to each sales channel i avg
According to formula PX i =FX i min ×a1+FX i max ×a2+FX i avg Calculating effective value PX corresponding to each sales channel by using Xa 3 i A1, a2 and a3 are respectively expressed as the set weight factors corresponding to the lowest drug effect score, the lowest drug effect score and the average drug effect score;
according to formula PJ i =FJ i min ×a4+FJ i max ×a5+FJ i avg Calculating price estimation PJ corresponding to each sales channel by using Xa 6 i A4, a5 and a6 are respectively expressed as weight factors corresponding to the set lowest drug price score, highest drug price score and average drug price score;
according to formula PY i =FY i min ×a7+FY i max ×a8+FY i avg Calculating the corresponding verification value PY of each sales channel by using the x a9 i A7, a8 and a9 are respectively represented as the set weight factors corresponding to the lowest purchase process experience score, the highest purchase process experience score and the highest purchase process experience score;
according to the formula KG i =YG i ×b1+PX i ×b2+PJ i ×b3+PY i Calculating feedback value KG of corresponding medicines of each sales channel in a set period by Xb 4 i B1, b2, b3, b4 are respectively represented as weights corresponding to the set speech estimation value, the set evaluation value, the set price estimation value, and the set test estimation value.
The medicine supply and marketing achievement evaluation module is used for extracting the manufacturing cost corresponding to the medicine from the database, analyzing the profit estimation value of the medicine corresponding to each sales channel in the setting period based on the total sales information of the medicine corresponding to each sales channel in the setting period and the manufacturing cost corresponding to the medicine, and obtaining the profit estimation value of the medicine corresponding to each sales channel in the setting period, wherein the specific analysis process is as follows:
extracting the total sales amount E of the corresponding medicines of each sales channel from the total sales information of the corresponding medicines of each sales channel in the set period i And total sales M i Extracting manufacturing cost C corresponding to the medicine from a database;
according to formula LG i =(E i ÷(M i X C))xu to calculate the profit value LG of the corresponding drug for each sales channel in the set period i U represents the set correction factor.
Analyzing the result value of the medicine corresponding to each sales channel in the set period based on the benefit evaluation value and the feedback evaluation value corresponding to each sales channel in the set period to obtain the result value of the medicine corresponding to each sales channel in the set period, wherein the specific calculation formula is as follows: CG (CG) i =KG i ×bk+LG i Xbg, wherein CG i The result value of the medicine corresponding to the ith sales channel in the set period is expressed, and bk and bg are respectively expressed as the set feedback value and the influence factor corresponding to the benefit value.
The medicine management scheme analysis module is used for analyzing the management scheme of corresponding medicine supply and sales based on the result value of the corresponding medicine of each sales channel in the set period to obtain the management scheme of corresponding medicine supply and sales, and sending the management scheme of corresponding medicine supply and sales to the value display processor, and further displaying the management scheme of corresponding medicine supply and sales through the display processor, wherein the analysis mode of the management scheme of corresponding medicine supply and sales is as follows:
and matching the result value of the medicine corresponding to each sales channel in the set period with the result value corresponding to each set management level to obtain the management level of the medicine corresponding to each sales channel, further matching the management level of the medicine corresponding to each sales channel with the management scheme corresponding to each set management level to obtain the management scheme of the medicine corresponding to each sales channel, and integrating the management schemes to obtain the management scheme of the medicine corresponding to supply and sales.
In a particular embodiment, the management levels include, but are not limited to, a first management level, a second management level, a third management level. Management schemes include, but are not limited to, reducing production, increasing production, expanding sales channels, and eliminating sales channels.
And the database is used for storing the influence factors corresponding to the word classes and storing the manufacturing cost corresponding to the medicine.
And the display processor is used for receiving the management scheme of corresponding marketing of the medicine sent by the medicine management scheme analysis module and displaying the management scheme.
The foregoing is merely illustrative and explanatory of the principles of the invention, as various modifications and additions may be made to the specific embodiments described, by those skilled in the art, or similar arrangements may be substituted, without departing from the principles of the invention or beyond the scope of the invention as defined in the description.

Claims (8)

1. A medication supply and marketing assessment management system, comprising:
the sales information acquisition module is used for acquiring the sales unit price of each medicine corresponding to each sales channel in the set period, and acquiring the total sales information of the medicine corresponding to each sales channel in the set period based on the sales unit price, wherein the total sales information comprises total sales amount and total sales amount;
the medicine feedback information sampling inspection module is used for acquiring contact information of buying staff corresponding to each medicine in each sales channel in a set period, randomly extracting contact information of a plurality of buying staff in the contact information of buying staff corresponding to each sales channel in the set period, marking the buying staff as feedback staff to acquire the contact information of feeding back staff corresponding to each sales channel in the set period, further carrying out a return visit on the feeding back staff corresponding to each sales channel according to a set return visit mode based on the contact information, and recording the return visit information to acquire feedback records of the feeding back staff corresponding to each sales channel in the set period, so as to analyze feedback evaluation values of the medicine corresponding to each sales channel in the set period and acquire feedback evaluation values of the medicine corresponding to each sales channel in the set period;
the medicine supply and marketing achievement evaluation module is used for extracting the manufacturing cost corresponding to the medicine from the database, analyzing the profit estimation value of the medicine corresponding to each sales channel in the setting period based on the total sales information of the medicine corresponding to each sales channel in the setting period and the manufacturing cost corresponding to the medicine, and obtaining the profit estimation value of the medicine corresponding to each sales channel in the setting period, so that the achievement value of the medicine corresponding to each sales channel in the setting period is analyzed based on the profit estimation value and the feedback estimation value corresponding to each sales channel in the setting period, and the achievement value of the medicine corresponding to each sales channel in the setting period is obtained;
the medicine management scheme analysis module is used for analyzing the management scheme of the corresponding supply and sales of the medicine based on the result value of the corresponding medicine of each sales channel in the set period to obtain the management scheme of the corresponding supply and sales of the medicine, sending the management scheme of the corresponding supply and sales of the medicine into the value display processor, and displaying the management scheme of the corresponding supply and sales of the medicine through the display processor;
and the database is used for storing the influence factors corresponding to the word classes and storing the manufacturing cost corresponding to the medicine.
2. The system according to claim 1, wherein the total sales information of the corresponding medicines in each sales channel in the set period is obtained by the following specific obtaining method:
accumulating the sales prices of the medicines corresponding to the sales channels in the set period to obtain the total sales amount of the medicines corresponding to the sales channels in the set period;
counting the corresponding medicines of each sales channel in the set period to obtain the total sales quantity of the corresponding medicines of each sales channel in the set period;
the total sales amount and the total sales amount of the medicines corresponding to each sales channel in the fixed period form the total sales information of the medicines corresponding to each sales channel in the set period.
3. The system according to claim 1, wherein the feedback records of the feedback personnel corresponding to the sales channels in the set period specifically include: drug effect score, drug price score, purchase process experience score, and supplemental opinion speech segment.
4. The system according to claim 1, wherein the analysis of the feed value of the corresponding medicine of each sales channel in the set period is performed to obtain the feed value of the corresponding medicine of each sales channel in the set period, and the specific analysis process is as follows:
extracting the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel from the feedback records of the sales channels corresponding to the feedback personnel in the set period, and analyzing the supplementary opinion voice segments of the sales channels corresponding to the feedback personnel to obtain the keyword number N of the sales channels corresponding to the word class i j Influence factor Y corresponding to each word class of each sales channel i j I is represented as the number of each sales channel, i=1, 2,.. i
Extracting the medicine effect score, the medicine price score and the purchasing process experience score of each sales channel corresponding to each feedback person from the feedback records of each sales channel corresponding to each feedback person in a set period, and screening the lowest medicine effect score FX corresponding to each sales channel i min Minimal drug effect score FX i max And calculating an average drug effect score FX corresponding to each sales channel i avg
Similarly, the lowest medicine price score FJ corresponding to each sales channel is obtained through analysis i min Maximum drug price score FJ i max And calculating an average drug price score FJ corresponding to each sales channel i avg
Similarly, the lowest purchase process experience score FY corresponding to each sales channel is obtained through analysis i min Highest purchase procedure experience score FY i max And calculating the highest purchase process experience score FY corresponding to each sales channel i avg
According to formula PX i =FX i min ×a1+FX i max ×a2+FX i avg Calculating effective value PX corresponding to each sales channel by using Xa 3 i A1, a2 and a3 are respectively expressed as the set weight factors corresponding to the lowest drug effect score, the lowest drug effect score and the average drug effect score;
according to formula PJ i =FJ i min ×a4+FJ i max ×a5+FJ i avg Calculating price estimation PJ corresponding to each sales channel by using Xa 6 i A4, a5 and a6 are respectively expressed as weight factors corresponding to the set lowest drug price score, highest drug price score and average drug price score;
according to formula PY i =FY i min ×a7+FY i max ×a8+FY i avg Calculating the corresponding verification value PY of each sales channel by using the x a9 i A7, a8 and a9 are respectively represented as the set weight factors corresponding to the lowest purchase process experience score, the highest purchase process experience score and the highest purchase process experience score;
according to the formula KG i =YG i ×b1+PX i ×b2+PJ i ×b3+PY i Calculating feedback value KG of corresponding medicines of each sales channel in a set period by Xb 4 i B1, b2, b3, b4 are respectively represented as set language estimates,The weight corresponding to the effective value, the price value and the check value.
5. The system of claim 4, wherein the analyzing the supplementary opinion speech segments of the sales channels corresponding to the feedback personnel to obtain the number of keywords of the sales channels corresponding to the word classes and the influence factors of the sales channels corresponding to the word classes comprises the following steps:
performing text conversion on the supplemental opinion voice segments of the corresponding feedback personnel of each sales channel to obtain supplemental opinion text fields of the corresponding feedback personnel of each sales channel;
matching the supplemental opinion text field of each feedback person corresponding to each sales channel with a set reject word, if the supplemental opinion text field of a certain feedback person is successfully matched with the set reject word, marking the feedback person as a person to be rejected, thereby obtaining each person to be rejected corresponding to each sales channel, rejecting the person to be rejected from each feedback person corresponding to each sales channel, and marking the rest feedback person as a marked person;
extracting the supplemental opinion text fields of the sales channels corresponding to the marking personnel from the supplemental opinion text fields of the feedback personnel corresponding to the sales channels, and extracting keywords from the supplemental opinion text fields to obtain the keywords of the supplemental opinion of the marking personnel in the sales channels;
word class identification is carried out on keywords of supplementary opinions corresponding to all marking persons in all sales channels, word classes of keywords of supplementary opinions corresponding to all marking persons in all sales channels are obtained, the same word classes are integrated, keywords of words corresponding to all sales channels are obtained, the number of keywords of words corresponding to all sales channels is counted, and meanwhile influence factors corresponding to words corresponding to all sales channels are matched with influence factors corresponding to words stored in a database, so that influence factors corresponding to words corresponding to all sales channels are obtained.
6. The system according to claim 4, wherein the analyzing the estimated value of the drug corresponding to each sales channel in the set period based on the total sales information of the drug corresponding to each sales channel in the set period and the manufacturing cost corresponding to the drug is performed to obtain the estimated value of the drug corresponding to each sales channel in the set period, and the specific analyzing process is as follows:
extracting the total sales amount E of the corresponding medicines of each sales channel from the total sales information of the corresponding medicines of each sales channel in the set period i And total sales M i Extracting manufacturing cost C corresponding to the medicine from a database;
according to formula LG i =(E i ÷(M i X C))xu to calculate the profit value LG of the corresponding drug for each sales channel in the set period i U represents the set correction factor.
7. The system according to claim 6, wherein the result value of the medicine corresponding to each sales channel in the set period is obtained by analyzing the result value of the medicine corresponding to each sales channel in the set period based on the profit value and the feed value corresponding to each sales channel in the set period, and the specific analysis formula is: CG (CG) i =KG i ×bk+LG i Xbg, wherein CG i The result value of the medicine corresponding to the ith sales channel in the set period is expressed, and bk and bg are respectively expressed as the set feedback value and the influence factor corresponding to the benefit value.
8. The system according to claim 1, wherein the analysis is performed on the management scheme of the corresponding marketing of the medicine based on the result value of the corresponding marketing of the medicine in each sales channel in the set period, so as to obtain the management scheme of the corresponding marketing of the medicine, and the specific analysis method is as follows: and matching the result value of the medicine corresponding to each sales channel in the set period with the result value corresponding to each set management level to obtain the management level of the medicine corresponding to each sales channel, further matching the management level of the medicine corresponding to each sales channel with the management scheme corresponding to each set management level to obtain the management scheme of the medicine corresponding to each sales channel, and integrating the management schemes to obtain the management scheme of the medicine corresponding to supply and sales.
CN202311587244.XA 2023-11-27 2023-11-27 Drug supply and marketing evaluation management system Pending CN117689404A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311587244.XA CN117689404A (en) 2023-11-27 2023-11-27 Drug supply and marketing evaluation management system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311587244.XA CN117689404A (en) 2023-11-27 2023-11-27 Drug supply and marketing evaluation management system

Publications (1)

Publication Number Publication Date
CN117689404A true CN117689404A (en) 2024-03-12

Family

ID=90134319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311587244.XA Pending CN117689404A (en) 2023-11-27 2023-11-27 Drug supply and marketing evaluation management system

Country Status (1)

Country Link
CN (1) CN117689404A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090045433A (en) * 2007-11-02 2009-05-08 정유근 Portal site business for marketing
CN109979111A (en) * 2019-03-26 2019-07-05 哈尔滨金鑫海文化传媒有限公司 One kind is self-service to sell medicine system
CN110555621A (en) * 2019-09-09 2019-12-10 郑植 Consumption market supervision informatization system
KR20220117425A (en) * 2021-02-17 2022-08-24 김현준 Marketability analysis and commercialization methodology analysis system using big data
CN115187065A (en) * 2022-07-11 2022-10-14 湖北帅锐服装贸易有限公司 Garment commodity quality analysis system based on electronic commerce platform
KR20230045204A (en) * 2021-09-28 2023-04-04 황희찬 Method, device and system for providing online lowest price product sales channel

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090045433A (en) * 2007-11-02 2009-05-08 정유근 Portal site business for marketing
CN109979111A (en) * 2019-03-26 2019-07-05 哈尔滨金鑫海文化传媒有限公司 One kind is self-service to sell medicine system
CN110555621A (en) * 2019-09-09 2019-12-10 郑植 Consumption market supervision informatization system
KR20220117425A (en) * 2021-02-17 2022-08-24 김현준 Marketability analysis and commercialization methodology analysis system using big data
KR20230045204A (en) * 2021-09-28 2023-04-04 황희찬 Method, device and system for providing online lowest price product sales channel
CN115187065A (en) * 2022-07-11 2022-10-14 湖北帅锐服装贸易有限公司 Garment commodity quality analysis system based on electronic commerce platform

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈培一: "《中国期刊广告实务研究》", 30 April 2006, 中央文献出版社, pages: 123 - 125 *

Similar Documents

Publication Publication Date Title
Chakraborty et al. Measuring consumer satisfaction in health care sector: the applicability of servqual
US20070219826A1 (en) Method and system for patient information processing and management
Forrey et al. Interrater agreement with a standard scheme for classifying medication errors
US20060293921A1 (en) Input device for web content manager responsive to browser viewers' psychological preferences, behavioral responses and physiological stress indicators
CN111341446B (en) Personalized physical examination package recommendation method
US20170177796A1 (en) Method and system for intelligent completion of medical record based on big data analytics
CN113345544A (en) Case scoring method, device and equipment and computer readable storage medium
Saunders et al. Electronic health records as a platform for audiological research: data validity, patient characteristics, and hearing-aid use persistence among 731,213 US veterans
WO2023035618A1 (en) Prescription generation method and apparatus based on natural language processing, and device and medium
Haque et al. Factors Affecting Customer’s Satisfaction and Loyalty in Hospitals in China
KR102546422B1 (en) System and method for managing patient customized care-service using voice communication base on AI
CN114420240A (en) Prescription management system based on artificial intelligence, big data and block chain
KR102483538B1 (en) System and method for predicting adaptability of taking medicine using machine learning
Khlie et al. Identification of the patient requirements using lean six sigma and data mining
KR101917852B1 (en) A System of Providing Hospital Management Consulting Service
CN116741360B (en) Doctor inquiry and service quality evaluation system based on intelligent terminal
US20130006711A1 (en) System and method for enhancing productivity of sales and marketing operations of pharmaceutical companies
CN117689404A (en) Drug supply and marketing evaluation management system
WO2020222202A1 (en) System and method for phrase comparison consolidation and reconciliation
KR20210130376A (en) System and method for providing information in order to choose pet's supplies
McFarland et al. Evaluation of patient experience with veterans affairs clinical pharmacist practitioners providing comprehensive medication management
US12027269B2 (en) Intelligent system and methods for automatically recommending patient-customized instructions
US20070012320A1 (en) Hair loss questionnaire system and method
EP3533024A1 (en) Extracting patient data to provide provider and patient data similarity scoring
US20130144638A1 (en) System and Method for Managing Consumer Data

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination